Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 4.8B | 5.3B | 4.9B | 4.8B |
| Cost of revenue | 2.8B | 3.0B | 2.8B | 2.8B |
| Gross profit | 2.0B | 2.3B | 2.0B | 2.0B |
| Operating expense | ||||
| Research & development | 344M | 344M | 316M | 327M |
| Selling general and admin | 1.0B | 1.1B | 1.0B | 1.1B |
| Other operating expenses | — | — | — | — |
| Operating income | 628M | 801M | 676M | 608M |
| Non operating interest income | ||||
| Income | — | — | 5M | 0 |
| Expense | 111M | 111M | 130M | 131M |
| Other income expense | 174M | 144M | 106M | 101M |
| Pretax income | 692M | 834M | 658M | 578M |
| Tax provision | 104M | 96M | 168M | 143M |
| Net income | 588M | 738M | 490M | 435M |
| Basic EPS | — | 1.6 | 1.0 | 0.9 |
| Diluted EPS | — | 1.6 | 1.0 | 0.9 |
| Basic average shares | — | 457M | 457M | 457M |
| Diluted average shares | — | 459M | 459M | 459M |
| EBITDA | 842M | 1.1B | 931M | 858M |
| Net income from continuing op. | 588M | 738M | 489M | 435M |
| Minority interests | -24M | -17M | -19M | -7M |
| Preferred stock dividends | — | — | — | — |